Article
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
American journal of human genetics - 1 May 1998
Conley M E, Mathias D, Treadaway J, Minegishi Y, Rohrer J
Abstract excerpt
In 1993, two groups showed that X-linked agammaglobulinemia (XLA) was due to mutations in a tyrosine kinase now called Btk. Most laboratories have been able to detect mutations in Btk in 80%-90% of males with presumed XLA. The remaining patients may have mutations in Btk that are difficult to identify, or they may have defects that are phenotypically similar to XLA but genotypically different. We analyzed 101...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
